Change in Management

Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 October 12, 2026 To Listing / Compliance Department Listing / Compliance Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE CODE: 543329 NSE SYMBOL: WINDLAS Dear Sir/ Madam, Sub: Intimation of change in the composition of the Board in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (‘Listing Regulations’), we wish to inform you that the Board of Directors vide its resolution dated October 12, 2026, has approved the following changes in composition of the Board: 1. Appointment of Mr. Aashish Mehra (DIN: 03142813) as an Additional Director/ Independent Director with effect from October 12, 2026, for a period of five consecutive years, based on the recommendation of Nomination & Remuneration Committee, subject to the approval of Shareholders; 2. Appointment of Mr. Soni Saran Singh (DIN: 01125022) as an Additional Director/ Independent Director with effect from October 12, 2026, for a period of five consecutive years, based on the recommendation of Nomination & Remuneration Committee, subject to the approval of Shareholders; and 3. Mr. Vivek Dhariwal (DIN: 02826679), has tendered his resignation as the Independent Director of the Company, with effect from close of business hours on October 12, 2026, citing personal reasons and prior commitments. Consequently, he shall also cease to be the Chairman of the Board and Member of the Nomination and Remuneration Committee and Corporate Social Responsibility Committee of the Company. The details for the aforesaid change in directorate as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular Ref: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, including a brief profile for the appointment of Mr. Aashish Mehra and Mr. Soni Saran Singh and resignation of Mr. Vivek Dhariwal are attached as Annexure I. The letter of resignation received from Mr. Vivek Dhariwal is enclosed as Annexure II. This is for your information and record. Thanking you, Yours faithfully, For Windlas Biotech Limited Ananta Narayan Panda Company Secretary & Compliance Officer www.windlas.com Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 Annexure I Details as per the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 A) APPOINTMENT OF MR. AASHISH MEHRA AS AN ADDITIONAL DIRECTOR/ INDEPENDENT DIRECTOR OF THE COMPANY Sr. Particulars Details 1. Reason for change viz. appointment/ re- Mr. Aashish Mehra has been appointed as an Additional appointment Director/ Independent Director w.e.f. October 12, 2026 for a period of 5 consecutive years, based on the recommendation of Nomination and Remuneration Committee subject to approval of Shareholders. 2. Date of appointment With effect from October 12, 2026 3. Brief profile (in case of appointment/ re- Mr. Aashish Mehra holds a B.Tech. Degree in appointment); Manufacturing Science and Engineering from IIT, Delhi and a P.G. Diploma in Computer-Aided Management from IIM, Calcutta. Mr. Aashish brings over two decades of strategy, consulting and business leadership experience, with particularly deep exposure to the pharmaceutical and life sciences industry. 4 Disclosure of relationships between Independent directors (in case of appointment of a director) 5 Information as required pursuant to Mr. Aashish Mehra is not debarred from holding the Circular No. LIST/COMP/14/2018-19 office of director by virtue of any SEBI order or any other issued by BSE Limited and Circular No. such authority. NSE/ CML/2018/24 issued by the National Stock Exchange of India Ltd., dated 20th June, 2018. B) APPOINTMENT OF MR. SONI SARAN SINGH AS AN ADDITIONAL DIRECTOR/ INDEPENDENT DIRECTOR OF THE COMPANY Sr. Particulars Details 1. Reason for change viz. appointment/ re- Mr. Soni Saran Singh has been appointed as an Additional appointment Director/ Independent Director w.e.f. October 12, 2026 for a period of 5 consecutive years, based on the recommendation of Nomination and Remuneration Committee subject to approval of Shareholders. 2. Date of appointment With effect from October 12, 2026 www.windlas.com Windlas Biotech Limited Reg. Off.: 40/1, Mohabewala Industrial Area Dehradun, Uttarakhand 248 110, India Tel.:+91-135-6608000-30, Fax:+91-135-6608199 Corp. Off.: 705-706, Vatika Professional Point, Sector-66, Golf Course Ext. Road, Gurgaon, Haryana 122 001, India Tel.:+91-124-2821030 CIN-L74899UR2001PLC033407 3. Brief profile (in case of appointment/ re- Mr. Soni Saran Singh holds a B.Sc. Degree in Mechanical appointment); Engineering from The Aligarh Muslim University and a P.G. Diploma in Marketing Management from Institute of Marketing & Management, New Delhi. Mr. Soni Saran Singh is a distinguished entrepreneur and business leader with over three decades of experience in the electronics manufacturing and technology sectors. He is the Founder, Managing Director & CEO of NMTronics India Pvt. Limited and its affiliated entities across India, Singapore, and the UAE. 4 Disclosure of relationships between Independent directors (in case of appointment of a director) 5 Information as required pursuant to Mr. Soni Saran Singh is not debarred from holding the Circular No. LIST/COMP/14/2018-19 office of director by virtue of any SEBI order or any other issued by BSE Limited and Circular No. such authority. NSE/ CML/2018/24 issued by the National Stock Exchange of India Ltd., dated 20th June, 2018. C) RESIGNATION OF MR. VIVEK DHARIWAL AS AN INDEPENDENT DIRECTOR OF THE COMPANY Sr. Particulars Details 1. Reason for change viz. appointment/ re- Mr. Vivek Dhariwal (DIN: 02826679) has tendered his appointment/ resignation resignation from the office of Director of the Company due to personal reasons and prior commitments He has also confirmed that there are no material reasons for his resignation other than those stated in his resignation letter. 2. Date of appointment/ cessation With effect from close of business hours on October 12, 2026 3. Brief profile (in case of appointment/ re- Not Applicable appointment); 4 Disclosure of relationships between Not Applicable directors (in case of appointment of a director) 5 Information as required pursuant to Not Applicable Circular No. LIST/COMP/14/2018-19 issued by BSE Limited and Circular No. NSE/ CML/2018/24 issued by the National Stock Exchange of India Ltd., dated 20th June, 2018. www.windlas.com Date: October 12, 2026 The Board of Directors Windlas Biotech Limited 40/1, Mohabewala Industrial Area, Dehradun -248 110 Uttarakhand, India Dear Sir/ Madam, Subject: Resignation from the Directorship of the Company I, Vivek Dhariwal (DIN: 02826679), hereby tender my resignation from the office of Independent Director of Windlas Biotech Limited (“the Company”) with effect from close of business hours on October 12, 2026, due to my personal reasons and prior commitments. Consequently, I will be stepping down from membership of Nomination and Remuneration Committee and Corporate Social Responsibility Committee of the Company. I [Showing first 8,000 characters — download PDF for full document]